Hyderabad-based Dr Reddy’s said it will also get exclusive commercial rights to market BAT2206 in Colombia as part of the deal. BAT2206 inhibits the bioactivity of human IL-12 and IL-23, both of ...

Guangzhou, China-based commercial-stage biopharmaceutical firm Bio-Thera Solutions and Hyderabad-based Dr. Reddy’s Laboratories, through one of its subsidiaries, signed commercialisation and ...